CUFO

This brand name is authorized in Nigeria

Active ingredients

The drug CUFO contains a combination of these active pharmaceutical ingredients (APIs):

1 Amylmetacresol
UNII 05W904P57F - AMYLMETACRESOL

Amylmetacresol is an antibacterial and antiviral agent, and blocks voltage-gated Na channels in a local anesthetic-like manner. It relieves symptoms of sore throat/irritation of the throat. Amylmetacresol is thought to inhibit the inflammatory and pain mediators that are involved in the inflammation of the mouth and throat mucous membranes, as well as the sore throat.

Read about Amylmetacresol
2 Dichlorobenzyl alcohol
UNII 1NKX3648J9 - DICHLOROBENZYL ALCOHOL

Dichlorobenzyl alcohol has antiseptic properties.

Read about Dichlorobenzyl alcohol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R02AA03 Dichlorobenzyl alcohol R Respiratory system → R02 Throat preparations → R02A Throat preparations → R02AA Antiseptics
Discover more medicines within R02AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: NG Registered Drug Product Database Identifier(s): B4-8934, B4-8935, B4-8936, B4-8937

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.